Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma. [electronic resource]
Producer: 20141215Description: 47 p. digitalISSN:- 2008-2231
- Adenocarcinoma -- drug therapy
- Animals
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Colonic Neoplasms -- drug therapy
- Female
- Humans
- Mice
- Mice, Inbred C57BL
- Neovascularization, Pathologic -- metabolism
- Pteridines -- pharmacology
- Transforming Growth Factor beta -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.